Kidney Cancer: Renal Cell vs. Transitional Cell Carcinoma – Origins and Spread

Kidney cancer comprises distinct histologic types with different origins, behaviors, and treatments.

1. Renal Cell Carcinoma (RCC) – 85-90%

  • Origin: Proximal tubular epithelium (nephron).
  • Subtypes: Clear cell (75%, VHL mutation), papillary (15%, MET), chromophobe (5%), collecting duct, unclassified.
  • Spread: Renal vein → IVC → lung, bone, liver, brain, contralateral kidney.
  • Staging: T1 (≤7 cm, confined) → T4 (beyond Gerota's fascia).

2. Transitional Cell Carcinoma (TCC) / Urothelial Carcinoma – 5-10%

  • Origin: Urothelium lining renal pelvis, ureters, bladder, urethra.
  • Same entity as bladder cancer – multifocal, field effect.
  • Spread: Intra-luminal → ureter → bladder; also hematogenous.
  • Risk factors: Smoking, analgesic abuse, aristolochic acid, Balkan endemic nephropathy.

Other Rare Types

  • Wilms tumor (children)
  • Renal sarcoma
  • Metastasis to kidney (lung, breast, melanoma most common)

Clinical Presentation

  • Hematuria (painless, microscopic or gross)
  • Flank pain, palpable mass
  • Paraneoplastic: polycythemia (EPO), hypercalcemia, Stauffer syndrome (liver dysfunction)

Diagnosis and Treatment

  • CT/MRI with contrast (renal mass protocol).
  • Biopsy if metastasized or nonsurgical candidate.
  • RCC: Partial/radical nephrectomy; systemic therapy (TKI, IO, combination) for advanced.
  • TCC: Nephroureterectomy + bladder cuff; intravesical/ systemic chemo for advanced.

Histology dictates management. Multidisciplinary tumor board optimizes care.

Kidney Disease - Related Articles